Cargando…
Anti-nuclear antibodies positive serum from systemic lupus erythematosus patients promotes cardiovascular manifestations and the presence of human antibody in the brain
BACKGROUND: Systemic lupus erythematosus (SLE) is characterized by the presence of anti-nuclear antibodies (ANAs) in the serum of patients. These antibodies may cross over into the brain resulting in the development of neuropsychiatric symptoms and result in abnormal pathology in other organs such a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097934/ https://www.ncbi.nlm.nih.gov/pubmed/25035640 http://dx.doi.org/10.4103/0975-7406.135247 |
_version_ | 1782326255406809088 |
---|---|
author | Kelly-Worden, Marie Hammer, Leslie Gebhard, Robyn Schrader, Lauran Griffin, Marley Cooper, Dalahnna |
author_facet | Kelly-Worden, Marie Hammer, Leslie Gebhard, Robyn Schrader, Lauran Griffin, Marley Cooper, Dalahnna |
author_sort | Kelly-Worden, Marie |
collection | PubMed |
description | BACKGROUND: Systemic lupus erythematosus (SLE) is characterized by the presence of anti-nuclear antibodies (ANAs) in the serum of patients. These antibodies may cross over into the brain resulting in the development of neuropsychiatric symptoms and result in abnormal pathology in other organs such as the heart and kidneys. OBJECTIVE: The objective of this study was to determine if SLE pathology could be detected in the hearts and brains of rats injected with positive human ANA serum. MATERIALS AND METHODS: Lewis rats (n = 31) were selected for this study due to documented research already performed with this strain in the investigation of serum sickness, encephalitis and autoimmune related carditis. Rats were injected once a week with either ANA positive or negative control serum or saline. Hearts were examined for initial signs of heart disease including the presence of lipid deposits, vegetation, increased ventricular thickness and a change in heart weight. Brains were examined for the presence of human antibody and necrotic lesions. Animals were observed for outward signs of neuropathy as well. Blood samples were taken in order to determine final circulating concentrations of IgG and monitor histamine levels. RESULTS: Animals injected with ANA were significantly higher for lipid deposits in the heart and an increased ventricular thickness was noted. One animal even displayed Libman-Sacks endocarditis. Brains were positive for the presence of human IgG and diffuse internal lesions occurred in 80% of the ANA positive serum injected animals examined. Blood histamine levels were not significantly different, but actually lower than controls by the end of the experiment. CONCLUSION: Since human antibodies were detected in the brain, further studies will have to identify which antibody cross reactions are occurring within the brain, examine cell infiltration as well as characterize the antibodies associated with more destructive consequences such as lesion formation. |
format | Online Article Text |
id | pubmed-4097934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-40979342014-07-17 Anti-nuclear antibodies positive serum from systemic lupus erythematosus patients promotes cardiovascular manifestations and the presence of human antibody in the brain Kelly-Worden, Marie Hammer, Leslie Gebhard, Robyn Schrader, Lauran Griffin, Marley Cooper, Dalahnna J Pharm Bioallied Sci Original Article BACKGROUND: Systemic lupus erythematosus (SLE) is characterized by the presence of anti-nuclear antibodies (ANAs) in the serum of patients. These antibodies may cross over into the brain resulting in the development of neuropsychiatric symptoms and result in abnormal pathology in other organs such as the heart and kidneys. OBJECTIVE: The objective of this study was to determine if SLE pathology could be detected in the hearts and brains of rats injected with positive human ANA serum. MATERIALS AND METHODS: Lewis rats (n = 31) were selected for this study due to documented research already performed with this strain in the investigation of serum sickness, encephalitis and autoimmune related carditis. Rats were injected once a week with either ANA positive or negative control serum or saline. Hearts were examined for initial signs of heart disease including the presence of lipid deposits, vegetation, increased ventricular thickness and a change in heart weight. Brains were examined for the presence of human antibody and necrotic lesions. Animals were observed for outward signs of neuropathy as well. Blood samples were taken in order to determine final circulating concentrations of IgG and monitor histamine levels. RESULTS: Animals injected with ANA were significantly higher for lipid deposits in the heart and an increased ventricular thickness was noted. One animal even displayed Libman-Sacks endocarditis. Brains were positive for the presence of human IgG and diffuse internal lesions occurred in 80% of the ANA positive serum injected animals examined. Blood histamine levels were not significantly different, but actually lower than controls by the end of the experiment. CONCLUSION: Since human antibodies were detected in the brain, further studies will have to identify which antibody cross reactions are occurring within the brain, examine cell infiltration as well as characterize the antibodies associated with more destructive consequences such as lesion formation. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4097934/ /pubmed/25035640 http://dx.doi.org/10.4103/0975-7406.135247 Text en Copyright: © Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kelly-Worden, Marie Hammer, Leslie Gebhard, Robyn Schrader, Lauran Griffin, Marley Cooper, Dalahnna Anti-nuclear antibodies positive serum from systemic lupus erythematosus patients promotes cardiovascular manifestations and the presence of human antibody in the brain |
title | Anti-nuclear antibodies positive serum from systemic lupus erythematosus patients promotes cardiovascular manifestations and the presence of human antibody in the brain |
title_full | Anti-nuclear antibodies positive serum from systemic lupus erythematosus patients promotes cardiovascular manifestations and the presence of human antibody in the brain |
title_fullStr | Anti-nuclear antibodies positive serum from systemic lupus erythematosus patients promotes cardiovascular manifestations and the presence of human antibody in the brain |
title_full_unstemmed | Anti-nuclear antibodies positive serum from systemic lupus erythematosus patients promotes cardiovascular manifestations and the presence of human antibody in the brain |
title_short | Anti-nuclear antibodies positive serum from systemic lupus erythematosus patients promotes cardiovascular manifestations and the presence of human antibody in the brain |
title_sort | anti-nuclear antibodies positive serum from systemic lupus erythematosus patients promotes cardiovascular manifestations and the presence of human antibody in the brain |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097934/ https://www.ncbi.nlm.nih.gov/pubmed/25035640 http://dx.doi.org/10.4103/0975-7406.135247 |
work_keys_str_mv | AT kellywordenmarie antinuclearantibodiespositiveserumfromsystemiclupuserythematosuspatientspromotescardiovascularmanifestationsandthepresenceofhumanantibodyinthebrain AT hammerleslie antinuclearantibodiespositiveserumfromsystemiclupuserythematosuspatientspromotescardiovascularmanifestationsandthepresenceofhumanantibodyinthebrain AT gebhardrobyn antinuclearantibodiespositiveserumfromsystemiclupuserythematosuspatientspromotescardiovascularmanifestationsandthepresenceofhumanantibodyinthebrain AT schraderlauran antinuclearantibodiespositiveserumfromsystemiclupuserythematosuspatientspromotescardiovascularmanifestationsandthepresenceofhumanantibodyinthebrain AT griffinmarley antinuclearantibodiespositiveserumfromsystemiclupuserythematosuspatientspromotescardiovascularmanifestationsandthepresenceofhumanantibodyinthebrain AT cooperdalahnna antinuclearantibodiespositiveserumfromsystemiclupuserythematosuspatientspromotescardiovascularmanifestationsandthepresenceofhumanantibodyinthebrain |